CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2025-06-30 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2024-09-23 | Klencke Barbara Director | Purchase | +5,000 | $5.29 | $26K | 45,000 |
| 2024-08-26 | Klencke Barbara Director | Purchase | +5,000 | $5.53 | $28K | 40,000 |
| 2024-08-23 | Klencke Barbara Director | Purchase | +5,000 | $5.69 | $28K | 35,000 |
| 2024-06-12 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +47,500 | 47,500 | ||
| 2023-12-14 | Klencke Barbara Director | Purchase | +5,000 | $5.08 | $25K | 30,000 |
| 2023-06-13 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +36,524 | 36,524 | ||
| 2023-04-06 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +9,146 | 9,146 |
Page 1 of 1 · 9 trades